PTC Therapeutics, Inc. <PTCT.O>: Wells Fargo Raises Target Price to $109 From $106
PTCT•Related News
Advanced Flower Capital Q2 net investment income rises 8% to $3.48 million; total investment income increases 8% to $8.69 million
AFCG•
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADCT•
CorMedix beats Q2 revenue estimates on DefenCath growth, raises FY adjusted EBITDA guidance
CRMD•
Birkenstock raises revenue forecast on strong demand, shares jump
BIRK•
CorMedix Q2 2026 net income rises 31.1% to $26 million; revenue more than doubled to $101.9 million
CRMD•